BMO Capital analyst Mike Murphy upgrades Crew Energy (TSX:CR) from Market Perform to Outperform and raises the price target from C$2.5 to C$3.25.
INOVIO, Advaccine Receive Regulatory Allowance For 2 Heterologous Prime-Boost Clinical Trials In China Using INO-4800, INOVIO’s COVID-19 DNA Vaccine Candidate
INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today announced that
